je.st
news
Tag: drug
Compugen Discloses Discovery Of Five Potential Cancer Targets For Antibody Drug Conjugate Therapy
2013-12-30 05:40:02| drugdiscoveryonline News Articles
Compugen Ltd. recently announced the predictive discovery and selection of five candidate targets for antibody-drug conjugate (ADC) cancer therapy
Tags: potential
drug
cancer
therapy
FDA Accepts For Review ELIQUIS (apixaban) Supplemental New Drug Application For The Treatment Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE), And For The Reduction In The Risk Of Recurrent DVT And PE
2013-12-30 05:21:47| drugdiscoveryonline News Articles
Bristol-Myers Squibb Company and Pfizer Inc. recently announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Supplemental New Drug Application (sNDA) for ELIQUIS (apixaban) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the reduction in the risk of recurrent DVT and PE
ANI Pharmaceuticals Buys 31 Generic Drug Products from Teva
2013-12-27 23:43:46| Biotech - Topix.net
ANI Pharmaceuticals, Inc. , an emerging generic pharmaceutical company, today announced that it has acquired 31 previously marketed generic drug products from Teva Pharmaceuticals for $12.5 million in cash and a percentage of future gross profits from product sales.
Tags: products
drug
generic
ani
Chinese drug maker probed after infant deaths tied to vaccine
2013-12-26 08:42:48| Biotech - Topix.net
Health authorities in China are investigating one of the nation's biggest vaccine makers after eight infants died in the past two months following injections that were meant to immunize them against hepatitis B. The government said this week that it had suspended the use of millions of doses of a hepatitis B vaccine produced by the manufacturer, ... (more)
Eli Lilly And Company And Boehringer Ingelheim Announce New Drug Application Filing In The U.S. For New Insulin Glargine Product
2013-12-23 00:57:30| drugdiscoveryonline News Articles
Eli Lilly and Company (NYSE:LLY) and Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) for LY2963016, an investigational basal (long-acting) insulin
Sites : [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] next »